Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Identifying mechanisms of metastatic Rhabdomyosarcoma using translational zebrafish modeling
EF 2023-24
Résumé
Rhabdomyosarcoma (RMS) is a rare cancer that manifests in soft tissues. Individuals can develop RMS at any age, however, it is most common in children. RMS has a good prognosis with 60-70% of cases ending up in remission if it is nonmetastatic and treated with a combination of chemotherapy, radiation, and surgery. However, once RMS spreads to secondary locations the percentage of cases that are cured decreases to 20%. This is due to a lack of understanding of what drives RMS progression and metastasis, leading to a limited number of targeted therapies. Zebrafish models of RMS are a useful tool for understanding the genetic pathways in vivo. As a model, zebrafish have several advantages such as their genetic similarity with humans, visual transparency, and the ability to be easily genetically modified. Due to the transparency of zebrafish, fluorescent transgenes can be used to visualize the tumour cells and their microenvironments, aiding us to grasp how the cancer grows and spreads. RMS can be quantified in real-time through transgenic gene over-expression and CRISPR/CAS9-mediated mutagenesis. I aim to use these methods and RNA sequencing to investigate the differences between metastatic and nonmetastatic tumours and to identify key genetic pathways behind RMS metastasis. Ultimately, this research will discover potential targets for future treatments for metastatic RMS.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506436
Name
McEwen Mairéad E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying mechanisms of metastatic Rhabdomyosarcoma using translational zebrafish modeling
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Crispr/Cas9; Genetic Pathways; Metastasis; Rhabdomyosarcoma; Therapeutics; Tp53; Tumour; Tumour Microenvrionments; Zebrafish
Abstract
Rhabdomyosarcoma (RMS) is a rare cancer that manifests in soft tissues. Individuals can develop RMS at any age, however, it is most common in children. RMS has a good prognosis with 60-70% of cases ending up in remission if it is nonmetastatic and treated with a combination of chemotherapy, radiation, and surgery. However, once RMS spreads to secondary locations the percentage of cases that are cured decreases to 20%. This is due to a lack of understanding of what drives RMS progression and metastasis, leading to a limited number of targeted therapies. Zebrafish models of RMS are a useful tool for understanding the genetic pathways in vivo. As a model, zebrafish have several advantages such as their genetic similarity with humans, visual transparency, and the ability to be easily genetically modified. Due to the transparency of zebrafish, fluorescent transgenes can be used to visualize the tumour cells and their microenvironments, aiding us to grasp how the cancer grows and spreads. RMS can be quantified in real-time through transgenic gene over-expression and CRISPR/CAS9-mediated mutagenesis. I aim to use these methods and RNA sequencing to investigate the differences between metastatic and nonmetastatic tumours and to identify key genetic pathways behind RMS metastasis. Ultimately, this research will discover potential targets for future treatments for metastatic RMS.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
McEwen, Mairéad E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~